Table 2.
Comparison of quantitative parameters pre- and post-immunotherapy in the effective group.
| Parameters | Pre-treatment | Post-treatment | t/Z | p |
|---|---|---|---|---|
| T1 (ms) | 1965.02 ± 210.34 | 1459.54 ± 535.96 | 3.109 | 0.008 c |
| ADC (×10–6 mm2/s) | 1425.41 ± 457.03 | 1913.39 ± 468.25 | -2.870 | 0.013 c |
| f (×10-3%) | 119.00 (86.60, 183.05) | 229.15 (131.60, 371.40) | 1.789 | 0.074 d |
| D (×10–6 mm2/s) | 1109.09 ± 208.06 | 1150.37 ± 360.51 | -0.355 | 0.729 c |
| D* (×10–5 mm2/s) | 825.42 ± 239.07 | 992.18 ± 382.20 | -1.277 | 0.224 c |
crepresents paired t-test; drepresents Wilcoxon signed-rank test.